Form 8-K - Current report:
SEC Accession No. 0000950170-25-090403
Filing Date
2025-06-26
Accepted
2025-06-26 16:16:01
Documents
32
Period of Report
2025-06-26
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K okur-20250626.htm   iXBRL 8-K 47912
2 EX-99.1 okur-ex99_1.htm EX-99.1 24260
3 GRAPHIC okur-ex99_1s1.jpg GRAPHIC 218292
4 GRAPHIC okur-ex99_1s2.jpg GRAPHIC 791128
5 GRAPHIC okur-ex99_1s3.jpg GRAPHIC 324707
6 GRAPHIC okur-ex99_1s4.jpg GRAPHIC 368601
7 GRAPHIC okur-ex99_1s5.jpg GRAPHIC 271982
8 GRAPHIC okur-ex99_1s6.jpg GRAPHIC 344446
9 GRAPHIC okur-ex99_1s7.jpg GRAPHIC 426731
10 GRAPHIC okur-ex99_1s8.jpg GRAPHIC 257026
11 GRAPHIC okur-ex99_1s9.jpg GRAPHIC 299792
12 GRAPHIC okur-ex99_1s10.jpg GRAPHIC 343289
13 GRAPHIC okur-ex99_1s11.jpg GRAPHIC 312732
14 GRAPHIC okur-ex99_1s12.jpg GRAPHIC 338482
15 GRAPHIC okur-ex99_1s13.jpg GRAPHIC 389861
16 GRAPHIC okur-ex99_1s14.jpg GRAPHIC 381208
17 GRAPHIC okur-ex99_1s15.jpg GRAPHIC 343563
18 GRAPHIC okur-ex99_1s16.jpg GRAPHIC 322276
19 GRAPHIC okur-ex99_1s17.jpg GRAPHIC 254468
20 GRAPHIC okur-ex99_1s18.jpg GRAPHIC 313410
21 GRAPHIC okur-ex99_1s19.jpg GRAPHIC 213117
22 GRAPHIC okur-ex99_1s20.jpg GRAPHIC 249894
23 GRAPHIC okur-ex99_1s21.jpg GRAPHIC 237418
  Complete submission text file 0000950170-25-090403.txt   9830212

Data Files

Seq Description Document Type Size
24 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT okur-20250626.xsd EX-101.SCH 24879
34 EXTRACTED XBRL INSTANCE DOCUMENT okur-20250626_htm.xml XML 4722
Mailing Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301
Business Address 6707 WINCHESTER CIRCLE, SUITE 400 BOULDER CO 80301 (720) 307-2892
OnKure Therapeutics, Inc. (Filer) CIK: 0001637715 (see all company filings)

EIN.: 472309515 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40315 | Film No.: 251080545
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)